[New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants]
{{output}}
Treatment of migraine attacks is advised in all patients, using non-steroidal anti-inflammatory drugs when the pain is mild and triptans when the pain intensity is moderate-severe. However, the effectiveness of these drugs is moderate, a high percentage of pat... ...
